期刊文献+

骨桥蛋白与基质金属蛋白酶9在子宫内膜病变中的表达 被引量:7

Expressions of Osteopontin and Matrix Metalloproteinase 9 in Endometrial Lesions
下载PDF
导出
摘要 目的检测骨桥蛋白(OPN)和基质金属蛋白酶9(MMP9)在正常子宫内膜、子宫内膜病变及子宫内膜腺癌组织中的表达情况,探讨2者与子宫内膜癌变发生、发展的关系。方法收集我院妇科经手术病理证实的子宫内膜腺癌标本75例、子宫内膜不典型增生标本22例及同期正常增殖期子宫内膜组织15例,采用免疫组织化学SP染色法检测OPN和MMP9的表达情况。结果在子宫内膜不典型增生及子宫内膜腺癌组织中,OPN与MMP9的阳性表达率分别为72.73%、80.00%和63.64%、70.67%,均明显高于正常增殖期子宫内膜组织(P<0.05)。OPN、MMP9的阳性表达率与子宫内膜腺癌的组织分级及肌层侵润呈正相关(r=0.287 9,P<0.05)。结论 OPN及MMP9与子宫内膜癌变发生及发展关系密切。 Objective To evaluate the expressions of osteopontin (OPN) and matrix metallopmteinase 9(MMP9) in normal and endome- trial pathology. To explore the relationship between the expressions of OPN, MMP9 and the genesis and development of endometrial adeno- carcinoma. Methods In this study, immunohistochemistry was used to investigate the expressions of OPN and MMP9 in 75 cases of en- dometrial adenocarcinoma,22 cases of atypical hyperplasia and 15 cases of normal proliferative endometrium. All the analysis was contirmed by surgical resection and pathology. Results In the cases of atypical hyperplasia and endometrial adenocarcinoma, the positive rates of OPN and MMP9 were 72.73%, 80.00% and 63.64%, 70.67%, respectively, Which were significantly higher than normal proliferative endometrium (P 〈 0.05). Expressions of OPN and MMP9 were significantly correlated with tumor grade, myometrial invasion of endometrial carcinoma (r =0.287 9, P 〈 0.05). Conclusion OPN and MMP9 were closely associated with tumor genesis and pathobiological behavior.
出处 《中国医科大学学报》 CAS CSCD 北大核心 2013年第1期49-51,55,共4页 Journal of China Medical University
基金 辽宁省教育厅高校科研计划(2008812)
关键词 骨桥蛋白 基质金属蛋白酶9 子宫内膜病理学 免疫组织化学 osteopontin matrix metalloproteinase 9 endometrial pathology immunohistochemistry
  • 相关文献

参考文献10

  • 1Rittling SR,Chambers AF. Role of osteopontin in tumour progression[J].British Journal of Cancer,2004,(10):1877-1881.
  • 2Coppola D,Szabo M,Boulware D. Correlation of osteopontin protein expression and pathological stage across a wide variety of tumor histologies[J].Clinical Cancer Research,2004,(01):184-190.
  • 3Macrì A,Versaci A,Lupo G. Role of osteopontin in breast cancer patients[J].Tumori,2009,(01):48-52.
  • 4于洪波,韩小兵,梁宜骞,刘建刚,王灏.OPN及survivin在前列腺癌组织中的表达及临床意义[J].南方医科大学学报,2010,30(5):1141-1143. 被引量:9
  • 5Lee SO,Jeong YJ,Kim M. Suppression of PMA-induced tumor cell invasion by capillarisin via the inhibition of NF-kappaB-dependent MMP-9 expression[J].Biochemical and Biophysical Research Communications,2008,(04):1019-1024.doi:10.1016/j.bbrc.2007.12.068.
  • 6王香平,陈升平,周莲娥.血清明胶酶(MMP-2、MMP-9)与子宫内膜癌[J].首都医科大学学报,2005,26(3):356-357. 被引量:1
  • 7Weber GF,Zawaideh S,Hikita S. Phosphorylation-dependent interaction of osteopontin with its receptors regulates macrophage migration and activation[J].Journal of Leukocyte Biology,2002,(04):752-761.
  • 8Rangaswami H,Bulbule A,Kundu GC. Nuclear factor inducing kinase:a key regulator in osteopontin-induced MAPK/IkappaB kinase dependent NF-kappaB-mediated promatrix metalloproteinase-9 activation[J].Glycoconjugate Journal,2006,(3-4):221-232.
  • 9Wang Y,Yan W,Lu X. Overexpression of osteopontin induces angiogenesis of endothelial progenitor cells via the avβ3/PI3K/AKT/eNOS/NO signaling pathway in glioma cells[J].European Journal of Cell Biology,2011,(08):642-648.
  • 10Vinothini G,Aravindraja C,Chitrathara K. Correlation of matrix metalloproteinases and their inhibitors with hypoxia and angiogenesis in premenopausal patients with adenocarcinoma of the breast[J].Clinical Biochemistry,2011,(12):969-974.

二级参考文献16

  • 1沈建军,刘家云,苏明权,缪应业,张青,郝晓柯.用RNAi沉默survivin基因表达对前列腺癌细胞系PC3的影响[J].中国肿瘤生物治疗杂志,2006,13(1):37-41. 被引量:4
  • 2张惠忠,刘金耿,魏益平,吴澄,曹永科,王梅.食管鳞癌RhoC和OPN蛋白的表达及其对患者预后的影响[J].南方医科大学学报,2006,26(11):1612-1615. 被引量:14
  • 3武金宝,南清振,马高峰,龚伟,陈琳,林英卓,王继德,张宏权,宋于刚.靶向抑制存活素基因对大肠癌细胞SW80侵袭和转移的实验研究[J].南方医科大学学报,2007,27(7):951-954. 被引量:2
  • 4Standal T, Borset M, Sundan A. Role of osteopontinin adhesion, migration, cell survival and bone remodeling[J]. Exp Oncol, 2004, 26(3): 179-84.
  • 5Strom A, Franzen A, Wangnerud C, et al. Altered vascular Remodeling in osteopontin deficient at herosclerotic mice [J]. J Vasc Res, 2004, 41(4): 314-22.
  • 6Li X, OR'egan AW, Berman JS. IFN-gamma induction of Osteopontin expression in human monocytoid cells [J ]. J Interferon Cytokine Res, 2003, 23(5): 259-65.
  • 7Gong J, Lee J, Akio H, et al. Attenuation of apoptosis by chromogranin A-induced Akt and survivin pathways in prostate cancer cells[J]. Endocrinology, 2007, 148(9): 4489-99.
  • 8Macrt A, Versaci A, Lupo G, et al. Role of osteopontin in breast cancer patients [J ]. Tumor, 2009, 95(1): 48-52.
  • 9Schneider S, Yochim J, Brabender J, et al. Osteopontin but not osteonectin messenger RNA expression is aprognostic Marker incuratively resected non-small cell lung cancer [J]. Clin Cancer Res, 2004, 10(5): 1588-96.
  • 10Ramankulov A, Lein M, Kristiansen G, et al. Plasma osteopontin in comparison with bone markers as indicator of bone metastasis and survival outcome in patients with prostate cancer[J ]. Prostate, 2007, 67(3): 330-40.

共引文献8

同被引文献78

  • 1詹阳,崔全才,师杰,罗玉凤,曹金伶.MMP2、MMP9、Galectin-3、CK19、及Ret在甲状腺滤泡型肿瘤中的表达[J].诊断病理学杂志,2005,12(2):126-128. 被引量:7
  • 2范宗宪,韩振强,于海江.鼻内翻性乳头状瘤及其癌变中CD105和VEGF表达的研究[J].黑龙江医药科学,2006,29(6):44-46. 被引量:3
  • 3Rittling S R,Chambers A F.Role of osteopontin in tumor progression[J].Br J Cancer,2004,90 (10):1877-1881.
  • 4Giaccone G.Treatment of malignant thymoma[J].Curr Opin Oncol,2005,17 (2):140-146.
  • 5Das R,Mahabeleshwar G H,Kundu G C.Osteopontin induces AP-1-mediated secretion of urokinase-type plasminogen activator through c-Src-Dependent epidermal growth factor receptor transactivation in breast cancer cells[J].Biol Chem,2004,279 (12):11050-11064.
  • 6Tracey L,Thomas J.Role of chemotherapy in the nlanagement of advanced thymic tumors[J].Semin Thorac Cardiovasc Surg,2005,17(1):41.
  • 7Golfman RL, Mosmann TR. CD4 T cell subsets: regulation of differentiation and founction[J]. IRes Immungl, 1991, 142: 7-9.
  • 8Horiuch I, Kawano Y, ho H, et al.Thl dominance in HAM/TSP and the optico-spinal form of multiple sclerosis versus Th2 dominance in mite antigen-specific IgE myelitis[J].J Neurol Sci, 2000,172 : 17-24.
  • 9Light GS Jr.Nodular goiter and benign and malignant neoplasms of the thyroid[M]//Sabiston DC J, eds. Textbook of surgery.15th ed.Philadelphia: WB Saunders Company, 1997 : 626,253-249.
  • 10谢多,陈薪,全松.基于循证医学的子宫内膜异位症合并不孕的治疗[J].生殖医学杂志,2014,23:508-512.

引证文献7

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部